Reps Schrier, Langworthy Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
unnecessary regulatory barriers, and help bring lower-cost prescription drugs to patients faster. “As a doctor with Type … deserve access to safe, effective, and more affordable prescription drugs, and one of the best ways to lower